Literature DB >> 26751558

Regulation of drug-metabolizing enzymes by local and systemic liver injuries.

Yan Guo1,2, Bingfang Hu1,3, Yang Xie1, Timothy R Billiar4, Jason L Sperry4, Min Huang3, Wen Xie1.   

Abstract

INTRODUCTION: Drug metabolism and disposition are critical in maintaining the chemical and functional homeostasis of xenobiotics/drugs and endobiotics. The liver plays an essential role in drug metabolism and disposition due to its abundant expression of drug-metabolizing enzymes (DMEs) and transporters. There is growing evidence to suggest that many hepatic and systemic diseases can affect drug metabolism and disposition by regulating the expression and/or activity of DMEs and transporters in the liver. AREAS COVERED: This review focuses on the recent progress on the regulation of DMEs by local and systemic liver injuries. Liver ischemia and reperfusion (I/R) and sepsis are used as examples of local and systemic injury, respectively. The reciprocal effect of the expression and activity of DMEs on animals' sensitivity to local and systemic liver injuries is also discussed. EXPERT OPINION: Local and systemic liver injuries have a major effect on the expression and activity of DMEs in the liver. Understanding the disease effect on DMEs is clinically important due to the concern of disease-drug interactions. Future studies are necessary to understand the mechanism by which liver injury regulates DMEs. Human studies are also urgently needed in order to determine whether the results in animals can be replicated in human patients.

Entities:  

Keywords:  Animal models; drug-metabolizing enzyme; ischemia and reperfusion; sepsis

Mesh:

Substances:

Year:  2016        PMID: 26751558      PMCID: PMC4861312          DOI: 10.1517/17425255.2016.1139574

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  63 in total

1.  The impact of liver dysfunction on outcome in patients with multiple injuries.

Authors:  B G Harbrecht; H R Doyle; K D Clancy; R N Townsend; T R Billiar; A B Peitzman
Journal:  Am Surg       Date:  2001-02       Impact factor: 0.688

2.  Estrogen Sulfotransferase Is an Oxidative Stress-responsive Gene That Gender-specifically Affects Liver Ischemia/Reperfusion Injury.

Authors:  Yan Guo; Bingfang Hu; Hai Huang; Allan Tsung; Nilesh W Gaikwad; Meishu Xu; Mengxi Jiang; Songrong Ren; Jie Fan; Timothy R Billiar; Min Huang; Wen Xie
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

3.  Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice.

Authors:  T Li-Masters; E T Morgan
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

4.  Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9.

Authors:  Jessica K Rieger; Sandra Reutter; Ute Hofmann; Matthias Schwab; Ulrich M Zanger
Journal:  Drug Metab Dispos       Date:  2015-03-23       Impact factor: 3.922

5.  Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats.

Authors:  P K Kim; J Chen; K M Andrejko; C S Deutschman
Journal:  Shock       Date:  2000-08       Impact factor: 3.454

6.  Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.

Authors:  E Siewert; R Bort; R Kluge; P C Heinrich; J Castell; R Jover
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

7.  Assessment of effects of IR and IPC on activities of cytochrome P450 isozymes in rats by a five-drug cocktail approach.

Authors:  Qin Li; Ying Liu; Jianjie Jiao; Caili Zhang; Jianshi Lou
Journal:  Drug Dev Ind Pharm       Date:  2013-01-23       Impact factor: 3.225

Review 8.  Animal models of human disease: inflammation.

Authors:  David R Webb
Journal:  Biochem Pharmacol       Date:  2013-06-26       Impact factor: 5.858

9.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.

Authors:  Edward T Chouchani; Victoria R Pell; Edoardo Gaude; Dunja Aksentijević; Stephanie Y Sundier; Ellen L Robb; Angela Logan; Sergiy M Nadtochiy; Emily N J Ord; Anthony C Smith; Filmon Eyassu; Rachel Shirley; Chou-Hui Hu; Anna J Dare; Andrew M James; Sebastian Rogatti; Richard C Hartley; Simon Eaton; Ana S H Costa; Paul S Brookes; Sean M Davidson; Michael R Duchen; Kourosh Saeb-Parsy; Michael J Shattock; Alan J Robinson; Lorraine M Work; Christian Frezza; Thomas Krieg; Michael P Murphy
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

10.  Oestrogen sulfotransferase ablation sensitizes mice to sepsis.

Authors:  Xiaojuan Chai; Yan Guo; Mengxi Jiang; Bingfang Hu; Zhigang Li; Jie Fan; Meihong Deng; Timothy R Billiar; Heidi R Kucera; Nilesh W Gaikwad; Meishu Xu; Peipei Lu; Jiong Yan; Haiyan Fu; Youhua Liu; Lushan Yu; Min Huang; Su Zeng; Wen Xie
Journal:  Nat Commun       Date:  2015-08-10       Impact factor: 14.919

View more
  7 in total

1.  Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO).

Authors:  Ai-Ming Yu; Magnus Ingelman-Sundberg; Nathan J Cherrington; Lauren M Aleksunes; Ulrich M Zanger; Wen Xie; Hyunyoung Jeong; Edward T Morgan; Peter J Turnbaugh; Curtis D Klaassen; Aadra P Bhatt; Matthew R Redinbo; Pengying Hao; David J Waxman; Li Wang; Xiao-Bo Zhong
Journal:  Acta Pharm Sin B       Date:  2017-02-01       Impact factor: 11.413

Review 2.  Cytochrome P450 Enzymes and Drug Metabolism in Humans.

Authors:  Mingzhe Zhao; Jingsong Ma; Mo Li; Yingtian Zhang; Bixuan Jiang; Xianglong Zhao; Cong Huai; Lu Shen; Na Zhang; Lin He; Shengying Qin
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

Review 3.  Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes.

Authors:  Yurong Song; Chenxi Li; Guangzhi Liu; Rui Liu; Youwen Chen; Wen Li; Zhiwen Cao; Baosheng Zhao; Cheng Lu; Yuanyan Liu
Journal:  Clin Pharmacokinet       Date:  2021-03-16       Impact factor: 6.447

4.  iTRAQ-Based Proteomic Profile Analysis of the Hepatopancreas of Caribbean Spiny Lobsters Infected With Panulirus argus Virus 1: Metabolic and Physiological Implications.

Authors:  Jesús Alejandro Zamora-Briseño; Eliel Ruiz-May; José Miguel Elizalde-Contreras; Ioreni Margarita Hernández-Velázquez; Ariadne Hernández-Pérez; Ana Guadalupe Fuentes-García; Nancy Herrera-Salvatierra; Patricia Briones-Fourzán; Cristina Pascual-Jiménez; Enrique Lozano-Álvarez; Rossanna Rodríguez-Canul
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

5.  Effects and Mechanism of Nano-Copper Exposure on Hepatic Cytochrome P450 Enzymes in Rats.

Authors:  Huaqiao Tang; Min Xu; Fei Shi; Gang Ye; Cheng Lv; Jie Luo; Ling Zhao; Yinglun Li
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

Review 6.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

7.  A prospective, phase II, single-centre, cross-sectional, randomised study investigating Dehydroepiandrosterone supplementation and its Profile in Trauma: ADaPT.

Authors:  Conor Bentley; Claire Potter; Kamal Makram Yakoub; Kristian Brock; Victoria Homer; Emma Toman; Angela E Taylor; Fozia Shaheen; Lorna C Gilligan; Amrita Athwal; Darren Barton; Ronald Carrera; Katie Young; Amisha Desai; Kirsty McGee; Christos Ermogenous; Gurneet Sur; Carolyn A Greig; Jon Hazeldine; Wiebke Arlt; Janet M Lord; Mark A Foster
Journal:  BMJ Open       Date:  2021-07-26       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.